Language
DEEN
Market analysis··2 min read

Market adjustment in the laboratory sector: New York life sciences real estate nears stabilisation

Following sales below development costs and project adjustments, New York life sciences real estate is showing initial signs of finding a floor.

AI generatedMarket adjustment in the laboratory sector: New York life sciences real estate nears stabilisation – AI-generated illustrative image
Market adjustment in the laboratory sector: New York life sciences real estate nears stabilisation. Illustrative image generated using artificial intelligence (AI). The image does not depict a real property, person or event and is not a documentary photograph. Labelled in accordance with Article 50(4) of the EU AI Act.

In September, the Iron Horse Labs project finally vanished from the Upper East Side market. Developer Taconic Partners sold the designated site at 309 East 94th Street, where an approximately 200,000 square foot Class A research facility was due to be built, to residential developer LCOR for $73 million. The sale marks another setback for the New York life sciences sector, where several laboratory assets across Manhattan and the surrounding boroughs were offloaded at a loss to owners outside the industry upon completion this year.

The development stands in sharp contrast to the momentum of 2020 and 2021, when the pandemic and sustained low interest rates channelled substantial investment into the biotechnology sector. Taconic had spun off its life sciences portfolio into subsidiary Elevate Research Properties in 2022 to hedge against what was then a weakening office market. While Manhattan office space has since seen a tangible recovery in demand, rental growth for research laboratories lagged behind. Today, only a single property remains in Elevate's New York portfolio.

Oversupply meets macroeconomic headwinds

Jonathan Schifrin, Senior Managing Director and head of life sciences at Savills in New York, describes the market situation as classic overdevelopment. Interest rate rises in 2022 dampened investor appetite, while cuts to federal research funding in 2025 placed additional strain on the industry. At the same time, newly delivered supply significantly outstripped demand from young start-ups. An industry report from JLL put the availability rate in New York City at 37 per cent in June, the highest figure nationwide.

Schifrin views the current development as an overdue market correction rather than a permanent crisis. Third-quarter data from Savills shows a decline in the vacancy rate for New York laboratories from 32.5 per cent in the previous quarter to 22.8 per cent, primarily driven by conversions and sales. The citywide total stock stands at 3.1 million square feet, with no new schemes currently under construction.

Subdued optimism driven by rising leasing activity

Leasing take-up in the Greater New York area reached 87,158 square feet in the third quarter of 2026 according to CoStar, up from 30,933 square feet in the previous quarter and just 9,883 square feet in the third quarter of 2025. Across the first nine months of 2026, volume totalled 143,098 square feet, compared with 61,433 square feet in the equivalent period of the previous year. Victor Rodriguez, Senior Director of Analytics at CoStar, considers the market to be in a very early stage of stabilisation, but stresses that it is still too early to speak of a full recovery.

  • —Largest deal of the year: Jackson Laboratory leased 41,000 square feet at the Hudson Research Center in Hell's Kitchen in January.
  • —Successful full occupancy: Rover Diagnostics secured 15,763 square feet in the InnoLabs property in Long Island City, Queens.
  • —Municipal support programmes: The Economic Development Corporation reaffirmed its $1 billion budget for the LifeSci NYC initiative, despite planned internal headcount reductions.

Industry observers attribute the success of individual schemes primarily to their completion timing. While developments brought to market late had to bear the full brunt of the cycle, established assets continue to secure solid occupier deals. Whether the market recovers sustainably will depend on the resilience of demand in the coming quarters.

Looking for
a real estate
agent?

Michael Freitag — founder of FREITAG® Immobilien
Michael Freitag
Founder of FREITAG® Immobilien GmbH
More than 15 years of experience in Bavaria & surroundings
— FREITAG Immobilien

Your discreet partner for institutional transactions in German-speaking Europe.

As a premium real estate firm based in Munich we advise investors, family offices, developers and long-term holders on the acquisition, sale and valuation of residential, income and commercial properties — confidential, close to the market and on equal terms.

3.600+
municipalities on our market radar
48 h
first assessment of your property
Off-market
discreet circle of buyers
DACH
DE · AT · CH
— Confidential contact

Let us talk about your portfolio.

Acquisition profiles, off-market opportunities, valuations or development enquiries — we reply personally within 24 hours, NDA as a matter of course.

Phone
+49 (0) 89 158 90 140
Email
E-Mail anzeigen
Office
Munich
— More news
— Most read in the journal